Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection
Deana Mikhalkova1, Sujata R Holman1, Hui Jiang2
1Cardiovascular Division, Department of Medicine, School of Medicine, Washington University, St Louis, Missouri, USA.
Insights
Gastric bypass surgery improved heart failure symptoms and cardiac function in obese women. Weight loss reduced cardiac mass and liver fat, but cardiac fat and lipid changes were not directly linked to functional improvements.
Area of Science:
- Cardiology
- Metabolic Surgery
- Obesity Medicine
Background:
- Obesity is a significant risk factor for heart failure with preserved ejection fraction (HFpEF).
- Myocardial lipid deposition and altered plasma lipidome are implicated in HFpEF pathogenesis.
- The impact of bariatric surgery on cardiac function and lipid metabolism in HFpEF remains incompletely understood.
Purpose of the Study:
- To investigate the effects of gastric bypass surgery on myocardial lipid deposition, cardiac function, and plasma lipidome in women with obesity and HFpEF.
Main Methods:
- A primary cohort of 12 women with HFpEF and obesity underwent echocardiography and magnetic resonance spectroscopy pre- and post-surgery (3 and 6 months).
- Plasma lipidomic analysis was performed pre-surgery and 3 months post-surgery.
- A validation cohort of 22 patients confirmed key findings.
Main Results:
- Gastric bypass surgery led to significant weight loss, reduced Minnesota Living with Heart Failure scores, decreased cardiac mass, and lowered liver fat.
- Echocardiography showed improved diastolic function (increased e'), but cardiac fat remained unchanged.
- Weight loss was associated with decreased plasma ceramide and sphingolipid species, yet these changes did not correlate with improvements in cardiac function.
Conclusions:
- Gastric bypass surgery ameliorates symptoms and improves cardiac remodeling and relaxation in women with obesity-related HFpEF.
- While surgery impacts the plasma sphingolipidome, improvements in cardiac function are not directly associated with these lipidomic changes or altered myocardial triglyceride content.
- Cardiac fat deposition and specific lipidomic alterations may not be the primary drivers of obesity-related HFpEF, suggesting alternative therapeutic targets.
Objective:
To determine the effects of gastric bypass on myocardial lipid deposition and function and the plasma lipidome in women with obesity and heart failure with preserved ejection fraction (HFpEF).
Methods:
A primary cohort (N = 12) with HFpEF and obesity underwent echocardiography and magnetic resonance spectroscopy both before and 3 months and 6 months after bariatric surgery. Plasma lipidomic analysis was performed before surgery and 3 months after surgery in the primary cohort and were confirmed in a validation cohort (N = 22).
Results:
After surgery-induced weight loss, Minnesota Living with Heart Failure questionnaire scores, cardiac mass, and liver fat decreased (P < 0.02, P < 0.001, and P = 0.007, respectively); echo-derived e' increased (P = 0.03), but cardiac fat was unchanged. Although weight loss was associated with decreases in many plasma ceramide and sphingolipid species, plasma lipid and cardiac function changes did not correlate.
Conclusions:
Surgery-induced weight loss in women with HFpEF and obesity was associated with improved symptoms, reverse cardiac remodeling, and improved relaxation. Although weight loss was associated with plasma sphingolipidome changes, cardiac function improvement was not associated with lipidomic or myocardial triglyceride changes. The results of this study suggest that gastric bypass ameliorates obesity-related HFpEF and that cardiac fat deposition and lipidomic changes may not be critical to its pathogenesis.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Heart Failure VII: Nursing Interventions

